These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30026825)

  • 1. The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.
    Zhuang W; Ma J; Chen X; Wang G; Lu J; Chen Y; Dong H; Cai S; Zhang Y; Zhao X; Zhu Y; Xu C; Huang Y; Huang Z; Zhu X; Jiang H; Wang Z
    J Cancer; 2018; 9(13):2302-2307. PubMed ID: 30026825
    [No Abstract]   [Full Text] [Related]  

  • 2. A scalable solution for tumor mutational burden from formalin-fixed, paraffin-embedded samples using the Oncomine Tumor Mutation Load Assay.
    Chaudhary R; Quagliata L; Martin JP; Alborelli I; Cyanam D; Mittal V; Tom W; Au-Young J; Sadis S; Hyland F
    Transl Lung Cancer Res; 2018 Dec; 7(6):616-630. PubMed ID: 30505706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma.
    Chen X; Ou Z; Wang L; Zhang Z; Fan X; Liu H; Wang W; Zhang Y; Zhu J; Liang X; Lou F; Cao S; Yao Y; Wang H; Yao X
    Mol Carcinog; 2022 Mar; 61(3):311-321. PubMed ID: 34729830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay.
    Quy PN; Kanai M; Fukuyama K; Kou T; Kondo T; Yamamoto Y; Matsubara J; Hiroshima A; Mochizuki H; Sakuma T; Kamada M; Nakatsui M; Eso Y; Seno H; Masui T; Takaori K; Minamiguchi S; Matsumoto S; Muto M
    Oncologist; 2019 Dec; 24(12):e1401-e1408. PubMed ID: 31186376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Damage Repair Gene Set as a Potential Biomarker for Stratifying Patients with High Tumor Mutational Burden.
    Chiu TY; Lin RW; Huang CJ; Yeh DW; Wang YC
    Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34198473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels.
    Endris V; Buchhalter I; Allgäuer M; Rempel E; Lier A; Volckmar AL; Kirchner M; von Winterfeld M; Leichsenring J; Neumann O; Penzel R; Weichert W; Glimm H; Fröhling S; Winter H; Herth F; Thomas M; Schirmacher P; Budczies J; Stenzinger A
    Int J Cancer; 2019 May; 144(9):2303-2312. PubMed ID: 30446996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
    Chalmers ZR; Connelly CF; Fabrizio D; Gay L; Ali SM; Ennis R; Schrock A; Campbell B; Shlien A; Chmielecki J; Huang F; He Y; Sun J; Tabori U; Kennedy M; Lieber DS; Roels S; White J; Otto GA; Ross JS; Garraway L; Miller VA; Stephens PJ; Frampton GM
    Genome Med; 2017 Apr; 9(1):34. PubMed ID: 28420421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer.
    Zhou Z; Li K; Wei Q; Chen L; Shuai Y; Wang Y; He K; Si L; Zhong Y; Lu J
    J Gastrointest Oncol; 2021 Dec; 12(6):2775-2787. PubMed ID: 35070406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing.
    Zhou C; Chen S; Xu F; Wei J; Zhou X; Wu Z; Zhao L; Liu J; Guo W
    Ann Transl Med; 2021 Sep; 9(18):1437. PubMed ID: 34733989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencing.
    Hatakeyama K; Nagashima T; Urakami K; Ohshima K; Serizawa M; Ohnami S; Shimoda Y; Ohnami S; Maruyama K; Naruoka A; Akiyama Y; Kusuhara M; Mochizuki T; Yamaguchi K
    Biomed Res; 2018; 39(3):159-167. PubMed ID: 29899191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
    Noskova H; Kyr M; Pal K; Merta T; Mudry P; Polaskova K; Ivkovic TC; Adamcova S; Hornakova T; Jezova M; Kren L; Sterba J; Slaby O
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
    Tian Y; Xu J; Chu Q; Duan J; Zhang J; Bai H; Yang Z; Fang W; Cai L; Wan R; Fei K; He J; Gao S; Zhang L; Wang Z; Wang J
    BMC Med; 2020 Aug; 18(1):232. PubMed ID: 32843031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor mutation burden calculation from gene panel sequencing data.
    Xu Z; Dai J; Wang D; Lu H; Dai H; Ye H; Gu J; Chen S; Huang B
    Onco Targets Ther; 2019; 12():3401-3409. PubMed ID: 31123404
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.
    Merino DM; McShane LM; Fabrizio D; Funari V; Chen SJ; White JR; Wenz P; Baden J; Barrett JC; Chaudhary R; Chen L; Chen WS; Cheng JH; Cyanam D; Dickey JS; Gupta V; Hellmann M; Helman E; Li Y; Maas J; Papin A; Patidar R; Quinn KJ; Rizvi N; Tae H; Ward C; Xie M; Zehir A; Zhao C; Dietel M; Stenzinger A; Stewart M; Allen J;
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing gene panels for tumor mutational burden estimation: the need to shift from 'correlation' to 'accuracy'.
    Wu HX; Wang ZX; Zhao Q; Wang F; Xu RH
    J Immunother Cancer; 2019 Aug; 7(1):206. PubMed ID: 31387639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer.
    Dai J; Jiang M; He K; Wang H; Chen P; Guo H; Zhao W; Lu H; He Y; Zhou C
    Front Oncol; 2021; 11():708294. PubMed ID: 34604048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients.
    Guo W; Fu Y; Jin L; Song K; Yu R; Li T; Qi L; Gu Y; Zhao W; Guo Z
    J Cancer; 2020; 11(4):883-892. PubMed ID: 31949492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study.
    Xiao Y; Lu D; Lei M; Xie W; Chen Y; Zheng Y; Wang C; Zhao J; Zhu Z; Zhao X; Huang M; Lin Y; Li Z; Yang L
    Ann Transl Med; 2021 Nov; 9(22):1661. PubMed ID: 34988170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor mutation burden in Chinese cancer patients and the underlying driving pathways of high tumor mutation burden across different cancer types.
    Jiao XD; Zhang XC; Qin BD; Liu D; Liu L; Ni JJ; Ning ZY; Chen LX; Zhu LJ; Qin SB; Ying SP; Chen XQ; Li AJ; Hou T; Han-Zhang H; Ye J; Zheng J; Chuai S; Zang YS
    Ann Transl Med; 2020 Jul; 8(14):860. PubMed ID: 32793704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.